Literature DB >> 7283031

Is routine crossmatching for two units of blood necessary in elective surgery?

S Argov, Y Shechter.   

Abstract

The usual preparation for many elective procedures calls for typing and crossmatching for 2 units of blood. Most of the blood prepared is not used. Every unit of blood kept for a specific patient is removed from the blood bank pool, thereby reducing its resources. Fourteen hundred of the most frequent elective operations were examined with regard to their blood utilization. A transfusion index was developed to determine whether preoperative crossmatching was justified. Applying the index to 1,400 elective procedures, it was found that only vascular procedures justified preoperative crossmatching. The safety of transfusion (elective and emergency) based on type and antibody screening is explained. The constant increase in blood consumption (as for open heart surgery) and the small increase in blood donations has created a blood shortage. It is suggested that surgeons stop requesting crossmatching for 2 units for those elective procedures in which blood is rarely used. This would decrease the workload in the blood bank and increase the blood bank pool without compromising patients' safety.

Entities:  

Mesh:

Year:  1981        PMID: 7283031     DOI: 10.1016/0002-9610(81)90351-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Implementation of Maximum Surgical Blood Ordering Schedule and an Improvement in Transfusion Practices of Surgeons subsequent to Intervention.

Authors:  Farheen Karim Mahar; Bushra Moiz; Mohammad Khurshid; Tabish Chawla
Journal:  Indian J Hematol Blood Transfus       Date:  2012-06-22       Impact factor: 0.900

2.  Use of blood in elective general surgery: an area of wasted resources.

Authors:  J A Smallwood
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

3.  Blood ordering habits for elective surgery: time for change.

Authors:  T Juma; A Baraka; M Abu-Lisan; S K Asfar
Journal:  J R Soc Med       Date:  1990-06       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.